1. Home
  2. INBS vs NBY Comparison

INBS vs NBY Comparison

Compare INBS & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$0.55

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

SELL

Current Price

$2.81

Market Cap

6.3M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
INBS
NBY
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
6.3M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
INBS
NBY
Price
$0.55
$2.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
148.5K
478.4K
Earning Date
11-12-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$3,292,042.00
$10,302,000.00
Revenue This Year
$778.48
$23.91
Revenue Next Year
N/A
$32.05
P/E Ratio
N/A
$108.80
Revenue Growth
3.26
390.34
52 Week Low
$0.56
$0.46
52 Week High
$2.75
$4.44

Technical Indicators

Market Signals
Indicator
INBS
NBY
Relative Strength Index (RSI) 28.68 86.06
Support Level $0.68 $1.00
Resistance Level $0.73 $1.11
Average True Range (ATR) 0.05 0.32
MACD 0.00 0.21
Stochastic Oscillator 5.41 82.68

Price Performance

Historical Comparison
INBS
NBY

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: